Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Hackensack University Medical Center
Information provided by (Responsible Party):
Hackensack University Medical Center Identifier:
First received: June 30, 2011
Last updated: August 21, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)